Our projects in Cambodia are currently focused on tackling hepatitis C and malaria.
We launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country.
Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.
The team started by screening HIV patients at the hospital for co-infection. In October, screening was expanded to include patients referred by the hospital’s hepatology department.
Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.